Free Trial
→ One tiny company just cracked Google’s $19B problem (From True Market Insiders) (Ad)tc pixel Free FULC Stock Alerts

Fulcrum Therapeutics (FULC) SEC Filings & 10K Form

Fulcrum Therapeutics logo
$6.88 +0.36 (+5.52%)
Closing price 09/4/2025 04:00 PM Eastern
Extended Trading
$6.88 0.00 (-0.07%)
As of 09/4/2025 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Fulcrum Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/28/2025
9:41 AM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
8:01 AM		Adage Capital Management, L.P. (Filed by)
Fulcrum Therapeutics (Subject)
Form SCHEDULE 13G/A
07/29/2025
7:34 AM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2025
7:39 AM		Fulcrum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2025
4:33 PM		Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G/A
05/01/2025
6:05 AM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
6:10 AM		Fulcrum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2025
8:35 AM		BlackRock, Inc. (Filed by)
Fulcrum Therapeutics (Subject)
Form SCHEDULE 13G/A
02/25/2025
6:21 AM		Fulcrum Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
6:05 AM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
6:10 AM		Fulcrum Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
8:32 AM		Adage Capital Management, L.P. (Filed by)
Fulcrum Therapeutics (Subject)
Form SCHEDULE 13G
01/28/2025
3:15 PM		Fulcrum Therapeutics (Issuer)
Musso Alan A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:00 AM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:50 PM		Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13G
12/23/2024
3:30 PM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:53 PM		Fulcrum Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/14/2024
3:25 PM		Fulcrum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
11/14/2024
5:15 AM		Fulcrum Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
11/13/2024
6:05 AM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
6:10 AM		Fulcrum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
2:51 PM		Fulcrum Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:49 AM		Fulcrum Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/07/2024
10:37 AM		FMR LLC (Filed by)
Fulcrum Therapeutics (Subject)
Form SC 13G/A
09/24/2024
3:05 PM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM		Fulcrum Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/20/2024
3:21 PM		Fulcrum Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
09/16/2024
7:21 PM		Fulcrum Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
09/12/2024
11:43 AM		Fulcrum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:FULC) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel
How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...
Brownstone Research | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...
SmartAsset | Sponsoredtc pixel
What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...
Reagan Gold Group | Sponsoredtc pixel
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...
Banyan Hill Publishing | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
For decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...
True Market Insiders | Sponsoredtc pixel